ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Lung Screening Study Ties Up Advisors, Board Sends It Back To NCI For Revision.

June 29, 2001

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995